Most Popular
-
1
Dongduk Women’s University halts coeducation talks
-
2
Defense ministry denies special treatment for BTS’ V amid phone use allegations
-
3
OpenAI in talks with Samsung to power AI features, report says
-
4
Russia sent 'anti-air' missiles to Pyongyang, Yoon's aide says
-
5
Two jailed for forcing disabled teens into prostitution
-
6
Trump picks ex-N. Korea policy official as his principal deputy national security adviser
-
7
S. Korea not to attend Sado mine memorial: foreign ministry
-
8
South Korean military plans to launch new division for future warfare
-
9
Kia EV9 GT marks world debut at LA Motor Show
-
10
Gold bars and cash bundles; authorities confiscate millions from tax dodgers
Myungmonon Pharm finalizes issuing price for US$19.5m capital increase
By 황유미Published : July 5, 2016 - 10:51
[DISCLOSURE] Myungmoon Pharm (017180) announced on July 5 that it has finalized the price of its new stocks at 4,995 won (US$4.35) per share. The company decided to issue 4.49 million shares for capital increase for equipment investment in May.
